INPATIENT CARE OF HEPATITIS C PATIENTS ON TELAPREVIR TREATMENT

被引：0
|
作者：
Erguel, Bilal [1 ]
Filik, Levent [1 ]
机构：
[1] Ankara Educ & Res Hosp, Dept Gastroenterol, Ankara, Turkey
来源：
GASTROENTEROLOGY NURSING | 2014年 / 37卷 / 01期
关键词：
COMBINATION THERAPY; RIBAVIRIN; INTERFERON; ADHERENCE;
D O I：
10.1097/SGA.0000000000000024
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [21] A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C
    Jacobson, I. M.
    Pawlotsky, J. -M.
    Afdhal, N. H.
    Dusheiko, G. M.
    Forns, X.
    Jensen, D. M.
    Poordad, F.
    Schulz, J.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 1 - 26
  • [22] Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
    Colombo, M.
    Fernandez, I.
    Abdurakhmanov, D.
    Ferreira, P. A.
    Strasser, S. I.
    Urbanek, P.
    Moreno, C.
    Streinu-Cercel, A.
    Verheyen, A.
    Iraqi, W.
    DeMasi, R.
    Hill, A.
    Laeuffer, J. M.
    Lonjon-Domanec, I.
    Wedemeyer, H.
    GUT, 2014, 63 (07) : 1150 - 1158
  • [23] Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C
    Buti, Maria
    Agarwal, Kosh
    Horsmans, Yves
    Sievert, William
    Janczewska, Ewa
    Zeuzem, Stefan
    Nyberg, Lisa
    Brown, Robert S., Jr.
    Hezode, Christophe
    Rizzetto, Mario
    Parana, Raymundo
    De Meyer, Sandra
    De Masi, Ralph
    Luo, Donghan
    Bertelsen, Kirk
    Witek, James
    GASTROENTEROLOGY, 2014, 146 (03) : 744 - +
  • [24] Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patients
    Kaya, Safak
    Aksoz, Selcuk
    Baysal, Birol
    Ay, Nurettin
    Danis, Ramazan
    INFECTIOUS DISEASES, 2015, 47 (09) : 658 - 661
  • [25] Efficacy and Safety of Telaprevir-Based Antiviral Treatment for Elderly Patients with Hepatitis C Virus
    Takita, Masahiro
    Hagiwara, Satoru
    Kudo, Masatoshi
    Kono, Masashi
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Kitai, Satoshi
    Yada, Norihisa
    Inoue, Tatsuo
    Minami, Yasunori
    Ueshima, Kazuomi
    ONCOLOGY, 2014, 87 : 110 - 117
  • [26] Impact of Age on Safety and Treatment Response in Patients with Hepatitis C (HCV) Treated With Boceprevir or Telaprevir
    Aronsohn, Andrew
    Stainbrook, Tuesdae
    Mohanty, Smruti
    Mubarak, Abdullah
    Spivey, James
    Pandya, Prashant K.
    Stewart, Thomas
    Fried, Michael W.
    Jacobson, Ira M.
    HEPATOLOGY, 2013, 58 : 218A - 218A
  • [27] EARLY TREATMENT RESULTS OF TELAPREVIR BASED TRIPLE REGIMENS IN CHRONIC HEPATITIS C PATIENTS IN TURKEY
    Aksu, F.
    Kurtaran, B.
    Inal, A.
    Ulu, A.
    Koemuer, S.
    Tasova, Y.
    Aksu, H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 227 - 227
  • [28] Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
    Sakin, Yusuf Serdar
    Polat, Zulfikar
    Demirci, Hakan
    Kekilli, Murat
    Uygun, Ahmet
    Bagci, Sait
    HEPATOLOGY RESEARCH, 2014, 44 (09) : 1037 - 1037
  • [29] Telaprevir Activity in Treatment-Naive Patients Infected With Hepatitis C Virus Genotype 4
    Sefcik, Roberta K.
    Bichoupan, Kian
    Martel-Laferriere, Valerie
    Odin, Joseph A.
    Liu, Lawrence U.
    Perumalswami, Ponni
    Bansal, Meena
    Dieterich, Douglas T.
    Ahmad, Jawad
    Schiano, Thomas D.
    Branch, Andrea D.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (11): : 1855 - 1856
  • [30] Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program
    Colombo, Massimo
    Strasser, Simone
    Moreno, Christophe
    Ferreira, Paulo Abrao
    Urbanek, Petr
    Fernandez, Inmaculada
    Abdurakmonov, Djamal
    Streinu-Cerce, Adrian
    Verheyen, Anke
    Iraqi, Wafae
    DeMasi, Ralph
    Hill, Andrew
    Lonjon-Domanec, Isabelle
    Wedemeyer, Heiner
    JOURNAL OF HEPATOLOGY, 2014, 61 (05) : 976 - 983
12345